You’ve accepted all cookies. You can change your cookie settings at any time.
The National Institute for Biological Standards and Control (NIBSC) will play a key role in evaluating vaccines that have been developed for COVID-19
The Medicines and Healthcare products Regulatory Agency (MHRA) is the latest regulator to join the Australia-Canada-Singapore-Switzerland (ACSS) Consortium.
The MHRA has published advice for patients and healthcare professionals
The Covert Human Intelligence Sources (CHIS) Bill will underpin the longstanding work of intelligence and law enforcement agencies.
Stronger warnings about the risk of dependence and addiction to be added to the patient information leaflet and discussed with patients
The MHRA will now issue all safety-critical alerts for medicines and medical devices that require action as National Patient Safety Alerts
Reporting suspected side effects or incidents to the Yellow Card scheme supports the safe use of medical products for everyone
Stephen Lightfoot will become Chair of the Medicines and Healthcare products Regulatory Agency (MHRA) from 1 September 2020.
People who take stimulant laxatives for constipation are being advised that these will now be sold in smaller packs, with on-pack warnings.
A new campaign to raise awareness of the fire risk and the precautions that need to be taken by users of skin creams has been launched today
Ground-breaking innovation to support medical technologies
The MHRA is aware of certificates being issued by certification bodies headed “certificates of compliance” or “Attestation of Compliance”.
Today’s publication of the Independent Medicines and Medical Devices Safety Review is of profound importance for the MHRA, since the safety of the public is our first priority.
Warning that thermal cameras and other such “temperature screening” products, some of which make direct claims to screen for COVID-19, are not a reliable way to detect if people have the virus.
Recent media reports have suggested that chloroquine can protect patients from coronavirus or treat COVID-19, the illness caused by a coronavirus.
The MHRA has approved the recruitment of further participants for a clinical trial by the University of Oxford
The Medicines and Healthcare products Regulatory Agency (MHRA) has instructed UK clinical trialists using hydroxychloroquine to treat or prevent coronavirus (COVID-19) to suspend recruitment of further participants.
A convicted fugitive faces the confiscation of £1.4 million in prime assets by the Crown, following a hearing at Southwark Crown Court today.
Anyone supplying these types of tests should temporarily stop this service.
MHRA has today given the first positive scientific opinion under the Early Access to Medicines Scheme (EAMS) for use of Gilead’s remdesivir.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.